Connor, Clark & Lunn Investment Management Ltd.
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1596800
VANCOUVER, A1
Position in TEVA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$14,213,356
+$10,692,113 QoQ
Shares Held
471,891
+170.7% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Connor, Clark & Lunn Investment Management Ltd. holds $123,963,967 across 16 Drug Manufacturers - Specialty & Generic names. TEVA ranks #4 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
649,629 | $31,279,636 | |
| 2 | ZTS |
Zoetis Inc.
|
187,329 | $22,144,161 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
153,755 | $20,255,683 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
471,891 | $14,213,356 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
868,325 | $12,069,717 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
1,835,424 | $6,442,338 | |
| 7 | EBS |
Emergent BioSolutions Inc.
|
648,377 | $5,381,529 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
382,976 | $5,304,217 |
All Filings in TEVA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,213,356 | 471,891 | Shares | Sole | 2026-05-11 | |
| 2025-09-30 | $3,521,243 | 174,319 | Shares | Sole | 2025-11-13 | |
| 2024-09-30 | $14,840,262 | 823,544 | Shares | Sole | 2024-11-08 | |
| 2023-03-31 | $347,212 | 39,233 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $391,412 | 42,918 | Shares | Sole | 2023-02-10 | |
| 2021-03-31 | $3,984,335 | 345,263 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $30,698,531 | 3,181,195 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $30,310,324 | 3,364,076 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $19,783,669 | 1,604,515 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,639,220 | 516,617 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||